Interventions to prevent hypothermia in extremely preterm low-weight infants undergoing cardiac catheterisation
Background In January 2019, a new device called the Amplatzer Piccolo Occluder was approved by the US Food and Drug Administration for percutaneous closure of patent ductus arteriosus in infants weighing more than 700 g and of postnatal age more than 3 days. Premature low-weight infants are predispo...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-09-01
|
Series: | BMJ Open Quality |
Online Access: | https://bmjopenquality.bmj.com/content/11/3/e001773.full |